Abiraterone Acetate Delays Quality of Life Decline in Men With Metastatic

Abiraterone Acetate Delays Quality Of Life Decline In Men With Metastatic
Abiraterone acetate, a recently FDA-approved drug used to treat men with metastatic castration-resistant prostate cancer, significantly delays progression of pain and quality of life deterioration when taken in conjunction with prednisone. The study … Read more on RedOrbit

Striking Solid Tumors: Transporting Treatments Safely and Effectively
Despite innovations in genomics and proteomics, the development of safe and effective drug delivery mechanisms while achieving the desired treatment benefit remains unmet. A myriad of causes lie … The benefits of radiation therapy have been … Read more on Genetic Engineering News

Cocaine exposure in the womb: The brain structure is intact but development is
Since adolescence is the typical period in life when substance use begins, researchers from the Yale University School of Medicine, led by Dr. Rajita Sinha, conducted a study to evaluate the gray matter differences and likelihood of substance use in … Read more on EurekAlert (press release)

New Recommendations on Treatments for Seizures in Autism
These included certain antiepileptic drugs (particularly valproate, lamotrigine, and levetiracetam), the ketogenic and modified Atkins diet, and immunomodulation and neurofeedback treatments. Treatment for … Most importantly, this study demonstrates … Read more on Sacramento Bee